• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A comparison of minimal residual disease detection in autografts among ASO-qPCR, droplet digital PCR, and next-generation sequencing in patients with multiple myeloma who underwent autologous stem cell transplantation.

作者信息

Takamatsu Hiroyuki, Wee Rachel K, Zaimoku Yoshitaka, Murata Ryoichi, Zheng Jianbiao, Moorhead Martin, Carlton Victoria E H, Kong Katherine A, Takezako Naoki, Ito Shigeki, Miyamoto Toshihiro, Yokoyama Kenji, Matsue Kosei, Sato Tsutomu, Kurokawa Toshiro, Yagi Hideo, Terasaki Yasushi, Ohata Kinya, Matsumoto Morio, Yoshida Takashi, Faham Malek, Nakao Shinji

机构信息

Haematology/Respiratory Medicine, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.

Division of Internal Medicine, Keiju Kanazawa Hospital, Kanazawa, Japan.

出版信息

Br J Haematol. 2018 Nov;183(4):664-668. doi: 10.1111/bjh.15002. Epub 2017 Dec 22.

DOI:10.1111/bjh.15002
PMID:29270982
Abstract
摘要

相似文献

1
A comparison of minimal residual disease detection in autografts among ASO-qPCR, droplet digital PCR, and next-generation sequencing in patients with multiple myeloma who underwent autologous stem cell transplantation.接受自体干细胞移植的多发性骨髓瘤患者中，ASO-qPCR、微滴式数字PCR和下一代测序在自体移植物中检测微小残留病的比较。
Br J Haematol. 2018 Nov;183(4):664-668. doi: 10.1111/bjh.15002. Epub 2017 Dec 22.
2
Prognostic value of sequencing-based minimal residual disease detection in patients with multiple myeloma who underwent autologous stem-cell transplantation.基于测序的微小残留病灶检测对接受自体造血干细胞移植的多发性骨髓瘤患者的预后价值。
Ann Oncol. 2017 Oct 1;28(10):2503-2510. doi: 10.1093/annonc/mdx340.
3
Comparison of Minimal Residual Disease Detection by Multiparameter Flow Cytometry, ASO-qPCR, Droplet Digital PCR, and Deep Sequencing in Patients with Multiple Myeloma Who Underwent Autologous Stem Cell Transplantation.多参数流式细胞术、等位基因特异性寡核苷酸定量聚合酶链反应、数字液滴聚合酶链反应和深度测序检测接受自体干细胞移植的多发性骨髓瘤患者微小残留病的比较
J Clin Med. 2017 Sep 25;6(10):91. doi: 10.3390/jcm6100091.
4
Minimal residual disease testing after stem cell transplantation for multiple myeloma.多发性骨髓瘤干细胞移植后的微小残留病检测
Bone Marrow Transplant. 2016 Jan;51(1):2-12. doi: 10.1038/bmt.2015.164. Epub 2015 Jul 20.
5
[Methods and clinical values for minimal residual disease detection in patients with multiple myeloma].[多发性骨髓瘤患者微小残留病检测的方法及临床价值]
Rinsho Ketsueki. 2018;59(10):2153-2161. doi: 10.11406/rinketsu.59.2153.
6
Molecular detection of minimal residual disease in multiple myeloma.多发性骨髓瘤微小残留病的分子检测。
Br J Haematol. 2018 Apr;181(1):11-26. doi: 10.1111/bjh.15075. Epub 2017 Dec 19.
7
Molecular remission after allogeneic or autologous transplantation of hematopoietic stem cells for multiple myeloma.多发性骨髓瘤造血干细胞异体或自体移植后的分子缓解
J Clin Oncol. 2000 Jun;18(11):2273-81. doi: 10.1200/JCO.2000.18.11.2273.
8
[Prognostic significance of sequencing-based MRD detection in multiple myeloma].[基于测序的微小残留病检测在多发性骨髓瘤中的预后意义]
Rinsho Ketsueki. 2015 Aug;56(8):989-96. doi: 10.11406/rinketsu.56.989.
9
Molecular and clinical remissions in multiple myeloma: role of autologous and allogeneic transplantation of hematopoietic cells.多发性骨髓瘤的分子与临床缓解：造血细胞自体及异基因移植的作用
J Clin Oncol. 1999 Jan;17(1):208-15. doi: 10.1200/JCO.1999.17.1.208.
10
[Prognostic value of minimal residual disease detection in multiple myeloma].[微小残留病检测在多发性骨髓瘤中的预后价值]
Nihon Rinsho. 2015 Jan;73(1):69-73.

引用本文的文献

1
Minimal Residual Disease Detection: Implications for Clinical Diagnosis and Cancer Patient Treatment.微小残留病检测：对临床诊断和癌症患者治疗的意义
MedComm (2020). 2025 May 15;6(6):e70193. doi: 10.1002/mco2.70193. eCollection 2025 Jun.
2
Digital Droplet PCR in Hematologic Malignancies: A New Useful Molecular Tool.数字液滴PCR在血液系统恶性肿瘤中的应用：一种新型实用的分子工具。
Diagnostics (Basel). 2022 May 24;12(6):1305. doi: 10.3390/diagnostics12061305.
3
A large-scale, multicentered trial evaluating the sensitivity and specificity of digital PCR versus ARMS-PCR for detecting ctDNA-based p.T790M in non-small-cell lung cancer patients.
一项评估数字PCR与ARMS-PCR检测非小细胞肺癌患者基于循环肿瘤DNA（ctDNA）的p.T790M的敏感性和特异性的大规模多中心试验。
Transl Lung Cancer Res. 2021 Oct;10(10):3888-3901. doi: 10.21037/tlcr-21-564.
4
Current and Emerging Applications of Droplet Digital PCR in Oncology: An Updated Review.液滴数字PCR在肿瘤学中的当前及新兴应用：最新综述
Mol Diagn Ther. 2022 Jan;26(1):61-87. doi: 10.1007/s40291-021-00562-2. Epub 2021 Nov 13.
5
RAS/RAF mutations in tumor samples and cell-free DNA from plasma and bone marrow aspirates in multiple myeloma patients.多发性骨髓瘤患者肿瘤样本以及血浆和骨髓穿刺液中游离DNA的RAS/RAF突变
J Cancer. 2020 Mar 15;11(12):3543-3550. doi: 10.7150/jca.43729. eCollection 2020.
6
Minimal Residual Disease Assessment Within the Bone Marrow of Multiple Myeloma: A Review of Caveats, Clinical Significance and Future Perspectives.多发性骨髓瘤骨髓中的微小残留病评估：对注意事项、临床意义及未来展望的综述
Front Oncol. 2019 Aug 20;9:699. doi: 10.3389/fonc.2019.00699. eCollection 2019.
7
Quality control and quantification in IG/TR next-generation sequencing marker identification: protocols and bioinformatic functionalities by EuroClonality-NGS.IG/TR 下一代测序标志物鉴定中的质量控制和定量：EuroClonality-NGS 的方案和生物信息学功能
Leukemia. 2019 Sep;33(9):2254-2265. doi: 10.1038/s41375-019-0499-4. Epub 2019 Jun 21.
8
Comparison of Minimal Residual Disease Detection by Multiparameter Flow Cytometry, ASO-qPCR, Droplet Digital PCR, and Deep Sequencing in Patients with Multiple Myeloma Who Underwent Autologous Stem Cell Transplantation.多参数流式细胞术、等位基因特异性寡核苷酸定量聚合酶链反应、数字液滴聚合酶链反应和深度测序检测接受自体干细胞移植的多发性骨髓瘤患者微小残留病的比较
J Clin Med. 2017 Sep 25;6(10):91. doi: 10.3390/jcm6100091.